Effect of Alteplase Use on Outcomes in Patients With Atrial Fibrillation: Analysis of the Initiation of Anticoagulation After Cardioembolic Stroke Study

BACKGROUND: Intravenous alteplase improves outcome after acute ischemic stroke without a benefit in 90‐day mortality. There are limited data on whether alteplase is associated with reduced mortality in patients with atrial fibrillation (AF)‐related ischemic stroke whose mortality rate is relatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaghi, Shadi, Mistry, Eva, de Havenon, Adam, Leon Guerrero, Christopher R., Nouh, Amre, Liberman, Ava L., Giles, James, Liu, Angela, Nagy, Muhammad, Kaushal, Ashutosh, Azher, Idrees, Mac Grory, Brian, Fakhri, Hiba, Brown Espaillat, Kiersten, Asad, Syed Daniyal, Pasupuleti, Hemanth, Martin, Heather, Tan, Jose, Veerasamy, Manivannan, Esenwa, Charles, Cheng, Natalie, Moncrieffe, Khadean, Moeini‐Naghani, Iman, Siddu, Mithilesh, Scher, Erica, Trivedi, Tushar, Wu, Teddy, Khan, Muhib, Keyrouz, Salah, Furie, Karen, Henninger, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475683/
https://www.ncbi.nlm.nih.gov/pubmed/34323120
http://dx.doi.org/10.1161/JAHA.121.020945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475683/
https://www.ncbi.nlm.nih.gov/pubmed/34323120
http://dx.doi.org/10.1161/JAHA.121.020945

Ejemplares similares